When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.To learn more about how CNN protects listener privacy, visit <a href="https://cnn.com/privacy">cnn.com/privacy</a> Learn more about your ad choices. Visit <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a>

Food for Thought, Literally

All over the world, there are people who are living extraordinary lives, full of happiness and health – and with hardly any heart disease, cancer or diabetes. Dr. Sanjay Gupta has been on a decades-long mission to understand how they do it, and how we can all learn from them. Scientists now believe we can even reverse the symptoms of Alzheimer’s dementia, and in fact grow sharper and more resilient as we age. Sanjay is a dad – of three teenage daughters, he is a doctor - who operates on the brain, and he is a reporter with more than two decades of experience - who travels the earth to uncover and bring you the secrets of the happiest and healthiest people on the planet – so that you too, can Chase Life.